Acelyrin Inc (SLRN)
3.14
-0.08
(-2.48%)
USD |
NASDAQ |
Dec 20, 16:00
3.145
0.00 (0.00%)
After-Hours: 20:00
Acelyrin Market Cap: 315.02M for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Pfizer Inc | 149.38B |
Bristol-Myers Squibb Co | 116.28B |
Biomarin Pharmaceutical Inc | 12.52B |
Lexicon Pharmaceuticals Inc | 258.36M |
Arbutus Biopharma Corp | 608.27M |
Market Cap Related Metrics
Price to Book Value | 0.5963 |
Price | 3.14 |
Earnings Yield | -78.34% |